Skip to content
ppharmaranks
Menu
Class IIOngoing

Med Pride, Bacitracin Zinc Ointment, 500 units, 0.9g packets Net Wt 130g, 144 count box, M… recall

FDA recall D-0635-2026 · initiated Jun 2, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jun 24, 2026How we research

Dabur India Limited recalled Med Pride, Bacitracin Zinc Ointment, 500 units, 0.9g packets Net Wt 130g, 144 co… in Jun 2026 — an FDA Class II recall (D-0635-2026) because CGMP Deviations; deficiencies observed during FDA inspection.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

CGMP Deviations; deficiencies observed during FDA inspection

The manufacturing process itself

The FDA found the process itself out of compliance, usually before any defective product was identified.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot# 007, 008, 009, 015, 016, Within Expiry.

Quantity recalled: 1087 tubes

Details

Product
Med Pride, Bacitracin Zinc Ointment, 500 units, 0.9g packets Net Wt 130g, 144 count box, Manufactured for: Shield Line LLC, 59 Hook Road, Bayonne, NJ 07002 USA, Made in India, UPC 3 52410 30352 4.
Recalling company
Dabur India Limited
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
US Nationwide.
Initiated
Jun 2, 2026
FDA report date
Jun 24, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Med Pride, Bacitracin Zinc Ointment, 500 units, 0.9g packets Net Wt 130g, 144 co… recalled?
Dabur India Limited recalled Med Pride, Bacitracin Zinc Ointment, 500 units, 0.9g packets Net Wt 130g, 144 co… in Jun 2026 — an FDA Class II recall (D-0635-2026) because CGMP Deviations; deficiencies observed during FDA inspection. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Med Pride, Bacitracin Zinc Ointment, 500 units, 0.9g packets Net Wt 130g, 144 co… recalled?
Per the FDA enforcement record, the reason for recall D-0635-2026 was: CGMP Deviations; deficiencies observed during FDA inspection
Is a recalled Med Pride, Bacitracin Zinc Ointment, 500 units, 0.9g packets Net Wt 130g, 144 co… dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Med Pride, Bacitracin Zinc Ointment, 500 units, 0.9g packets Net Wt 130g, 144 co… are affected?
Distributed: US Nationwide.. The recall covers these lots — Lot# 007, 008, 009, 015, 016, Within Expiry.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0635-2026.

Source: openFDA Drug Enforcement record D-0635-2026

← All drug recalls